Denglu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Denglu Zhang has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Dongfang Lv
College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
2 shared publicationsHuihui Jiang
Clinical Laboratory, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
2 shared publications- Lei Qi
Central Laboratory, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, 250011, China
2 shared publications - Shengtian Zhao
Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University
2 shared publications - Weipin Niu
Central Laboratory, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, 250011, China
2 shared publications Xianzhen Yang
Department of Urology, Shandong Provincial Hospital, Shandong University
2 shared publications
Latest Publications
- 23 January 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 361, 121246
Banxia Baizhu Tianma Decoction attenuates obesity via regulating adipocyte-immune cell communication
- 23 January 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 361, 121246
Banxia Baizhu Tianma Decoction attenuates obesity via regulating adipocyte-immune cell communication
- Open Access
- 18 August 2025
- Published by Elsevier in Pharmacological Research
- Vol. 219, 107915
Precision targeting of androgen receptor–ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies
- 18 August 2025
- Published by Elsevier in Pharmacological Research
- Vol. 219, 107915
Open AccessPrecision targeting of androgen receptor–ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies
- Open Access
- 1 May 2025
- Published by KEAI Publishing in Genes & Diseases
- Vol. 12 (3) , 101451
Research progress on the use of traditional Chinese medicine to treat diseases by regulating ferroptosis
Ferroptosis is an emerging form of programmed cell death triggered by iron-dependent lipid peroxidation. It is distinguished from other forms of cell death by its unique morphological changes and characteristic fine-tuned regulatory gene network. Since its pivotal involvement in the pathogenesis and therapeutic interventions of various diseases, such as malignant tumors, cardiovascular and cerebrovascular diseases, and traumatic disorders, has been well-established, ferroptosis has garnered significant attention in contemporary physiological and pathological research. For the advantage of alleviating the clinical symptoms and improving life quality, traditional Chinese medicine (TCM) holds a significant position in the treatment of these ailments. Moreover, increasing studies revealed that TCM compounds and monomers showed evident therapeutic efficacy by regulating ferroptosis via signaling pathways that tightly regulate redox reactions, iron ion homeostasis, lipid peroxidation, and glutathione metabolism. In this paper, we summarized the current knowledge of TCM compounds and monomers in regulating ferroptosis, aiming to provide a comprehensive review of disease management by TCM decoction, Chinese patent medicine, and natural products deriving from TCM through ferroptosis modulation. The formulation composition, chemical structure, and possible targets or mechanisms presented here offer valuable insights into the advancement of TCM exploration.
- 1 May 2025
- Published by KEAI Publishing in Genes & Diseases
- Vol. 12 (3) , 101451
Open AccessResearch progress on the use of traditional Chinese medicine to treat diseases by regulating ferroptosis
Ferroptosis is an emerging form of programmed cell death triggered by iron-dependent lipid peroxidation. It is distinguished from other forms of cell death by its unique morphological changes and characteristic fine-tuned regulatory gene network. Since its pivotal involvement in the pathogenesis and therapeutic interventions of various diseases, such as malignant tumors, cardiovascular and cerebrovascular diseases, and traumatic disorders, has been well-established, ferroptosis has garnered significant attention in contemporary physiological and pathological research. For the advantage of alleviating the clinical symptoms and improving life quality, traditional Chinese medicine (TCM) holds a significant position in the treatment of these ailments. Moreover, increasing studies revealed that TCM compounds and monomers showed evident therapeutic efficacy by regulating ferroptosis via signaling pathways that tightly regulate redox reactions, iron ion homeostasis, lipid peroxidation, and glutathione metabolism. In this paper, we summarized the current knowledge of TCM compounds and monomers in regulating ferroptosis, aiming to provide a comprehensive review of disease management by TCM decoction, Chinese patent medicine, and natural products deriving from TCM through ferroptosis modulation. The formulation composition, chemical structure, and possible targets or mechanisms presented here offer valuable insights into the advancement of TCM exploration.
- Open Access
- 2 March 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2471011
The association between immune cells and acute kidney injury: insights from Mendelian randomization
Immune disorder is a prominent feature of acute kidney injury (AKI). However, the specific role of different immune cell phenotypes in the pathogenesis of AKI remains poorly understood. The aim of this study was to investigate the relevance of 731 immune phenotypes to AKI. We obtained data on 731 immune cell phenotypes from the GWAS Catalog and Open GWAS databases and undertook a series of quality control measures to identify exposure-related instrumental variables (IV). Data on acute renal failure (ARF) and rapid kidney function decline were obtained from the Finngen R11 and CKDGen databases as an outcome. Subsequently, we performed two-sample Mendelian randomization (MR) using inverse variance weights to explore the causal relationship between 731 immune cell characteristics and ARF and rapid kidney function declineas at the gene level. Sensitivity analyses, including leave-one-out and other MR analysis models, were performed. At the significance level corrected by Bonferroni, 9 immune phenotypes, including CD25 on IgD + CD24- B cell, were associated with ARF; 4 immune phenotypes, including SSC-A on plasmacytoid dendritic cell, were associated with rapid kidney function decline. Sensitivity analysis indicated robust results. Our study demonstrates a strong causal relationship between specific types of immune cells and AKI by genetic means, providing valuable insights for future clinical studies.
- 2 March 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2471011
Open AccessThe association between immune cells and acute kidney injury: insights from Mendelian randomization
Immune disorder is a prominent feature of acute kidney injury (AKI). However, the specific role of different immune cell phenotypes in the pathogenesis of AKI remains poorly understood. The aim of this study was to investigate the relevance of 731 immune phenotypes to AKI. We obtained data on 731 immune cell phenotypes from the GWAS Catalog and Open GWAS databases and undertook a series of quality control measures to identify exposure-related instrumental variables (IV). Data on acute renal failure (ARF) and rapid kidney function decline were obtained from the Finngen R11 and CKDGen databases as an outcome. Subsequently, we performed two-sample Mendelian randomization (MR) using inverse variance weights to explore the causal relationship between 731 immune cell characteristics and ARF and rapid kidney function declineas at the gene level. Sensitivity analyses, including leave-one-out and other MR analysis models, were performed. At the significance level corrected by Bonferroni, 9 immune phenotypes, including CD25 on IgD + CD24- B cell, were associated with ARF; 4 immune phenotypes, including SSC-A on plasmacytoid dendritic cell, were associated with rapid kidney function decline. Sensitivity analysis indicated robust results. Our study demonstrates a strong causal relationship between specific types of immune cells and AKI by genetic means, providing valuable insights for future clinical studies.
- Open Access
- 16 February 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1294807
Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury
Acute kidney injury (AKI) is characterized by a rapid decline in renal function and is associated with a high morbidity and mortality rate. At present, the underlying mechanisms of AKI remain incompletely understood. Immune disorder is a prominent feature of AKI, and dendritic cells (DCs) play a pivotal role in orchestrating both innate and adaptive immune responses, including the induction of protective proinflammatory and tolerogenic immune reactions. Emerging evidence suggests that DCs play a critical role in the initiation and development of AKI. This paper aimed to conduct a comprehensive review and analysis of the role of DCs in the progression of AKI and elucidate the underlying molecular mechanism. The ultimate objective was to offer valuable insights and guidance for the treatment of AKI.
- 16 February 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1294807
Open AccessAdvances in understanding of dendritic cell in the pathogenesis of acute kidney injury
Acute kidney injury (AKI) is characterized by a rapid decline in renal function and is associated with a high morbidity and mortality rate. At present, the underlying mechanisms of AKI remain incompletely understood. Immune disorder is a prominent feature of AKI, and dendritic cells (DCs) play a pivotal role in orchestrating both innate and adaptive immune responses, including the induction of protective proinflammatory and tolerogenic immune reactions. Emerging evidence suggests that DCs play a critical role in the initiation and development of AKI. This paper aimed to conduct a comprehensive review and analysis of the role of DCs in the progression of AKI and elucidate the underlying molecular mechanism. The ultimate objective was to offer valuable insights and guidance for the treatment of AKI.
- 24 January 2024
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 390, 110878
DIA proteomics analysis reveals the mechanism of folic acid-induced acute kidney injury and the effects of icariin
- 24 January 2024
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 390, 110878
DIA proteomics analysis reveals the mechanism of folic acid-induced acute kidney injury and the effects of icariin